Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 32 | Cunningham Bradley KramerChief Technology Officer |  PAYSPaysign, Inc.Open-market sale | SELL | $23K 3,000 sh | Sep 4, 2026 |
| 32 | Coloma Jason VDirector, Chief Executive Officer | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $3,325 129 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 32 | Bonanni Mark EmilioEVP, CRO, Commercial |  OUTOUTFRONT Media Inc.Open-market sale | SELL | $101K 3,385 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 32 | Courtney PhillipsGC and Corp. Secretary | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $567 22 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 31 | Lantheus Alpha Therapy, LLC10% Owner |  CATXPerspective Therapeutics, Inc.Open-market sale | SELL | $112K 35.8K sh | Sep 4, 2026 traded Sep 1, 2026 |
| 31 | Moatazedi DavidDirector, See Remarks |  EOLSEvolus, Inc.Open-market sale | SELL | $950K 105.1K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 31 | Quirk Steven M.Chief Brokerage Officer | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $1.58M 13.2K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 31 | Boyan GeorgeDirector, President |  UNTYUNITY BANCORP INC /NJ/Open-market sale | SELL | $385K 6,504 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 30 | Turner Matthew BakerPRES., PATIENT AFFORDABILITY | PAYSPaysign, Inc. Tax withholding | F | $341K 50.7K sh | Sep 4, 2026 traded May 22, 2026 |
| 30 | Lacerte Rene A.Director, CEO |  BILLBILL Holdings, Inc.Open-market sale | SELL | $291K 5,752 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 29 | Schafer Douglas M. JREVP and CIO | MIAXMIAMI INTERNATIONAL HOLDINGS, INC. Open-market sale · 10b5-1 plan | SELL | $1.94M 48.0K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 29 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $17K 625 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 29 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $11K 391 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 29 | Holland Noel R.Director |  CLBKColumbia Financial, Inc./MD/Open-market purchase | BUY | $234 20 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 29 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $929 36 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 29 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale | SELL | $1,521 59 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 29 | Comly Barbara J.EVP, GC & Corporate Secretary | MIAXMIAMI INTERNATIONAL HOLDINGS, INC. Open-market sale · 10b5-1 plan | SELL | $1.80M 44.4K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 28 | Carlin PeterDirector |  ADNTAdient plcOpen-market sale | SELL | $151K 7,843 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 27 | Caezza NicholasDeputy General Counsel |  BFLYButterfly Network, Inc.Open-market sale | SELL | $14K 1,709 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 27 | Ravin Seth A.Director, President, CEO & Chairman, 10% Owner |  RMNIRimini Street, Inc.Open-market sale | SELL | $992K 191.7K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 27 | Cunningham Bradley KramerChief Technology Officer | PAYSPaysign, Inc. Tax withholding | F | $73K 12.4K sh | Sep 4, 2026 traded May 18, 2026 |
| 26 | Spetzler David BaxleyPresident |  CAICaris Life Sciences, Inc.Option exercise | M | $2.44M 1.00M sh | Sep 4, 2026 traded Sep 3, 2026 |
| 26 | Deitzel EdwardEVP, CRO, CCO MIAX Exchanges | MIAXMIAMI INTERNATIONAL HOLDINGS, INC. Open-market sale · 10b5-1 plan | SELL | $464K 11.0K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 26 | Marquina JavierDirector |  LPALogistic Properties of the AmericasOpen-market sale | SELL | $5,421 1,760 sh | Sep 4, 2026 traded Sep 4, 2026 |
| 25 | Pylypiv MariyaChief Financial Officer |  AIROAIRO Group Holdings, Inc.Open-market sale | SELL | $62K 8,697 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 25 | Lantheus Alpha Therapy, LLC10% Owner | CATXPerspective Therapeutics, Inc. Open-market sale | SELL | $131K 42.1K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 25 | Hinchcliffe DionDirector |  INTZINTRUSION INCOpen-market sale | SELL | $12K 15.0K sh | Sep 4, 2026 traded Sep 4, 2026 |
| 25 | Gallagher Thomas P.Director, Chairman & CEO | MIAXMIAMI INTERNATIONAL HOLDINGS, INC. Open-market sale · 10b5-1 plan | SELL | $1.99M 47.0K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 24 | Gallagher Daniel Martin JrChief Legal Officer | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $335K 2,700 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 24 | Ware J. AnthonyDirector |  TRAXFirst Tracks Biotherapeutics, Inc.Option exercise | M | $225K 39.3K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 24 | Quirk Steven M.Chief Brokerage Officer | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $271K 2,397 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 24 | Gallagher Daniel Martin JrChief Legal Officer | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $467K 3,800 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 24 | Andzejevska IlonaDirector, President,Treasurer,CEO,CFO, 10% Owner |  RADCReadvantage Corp.Other acquisition or disposition | J | — 1.50M sh | Sep 4, 2026 traded Sep 3, 2026 |
| 24 | Bement Kenneth BChief Accounting Officer |  TRMBTRIMBLE INC.Option exercise | M | $239K 4,056 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 24 | Quirk Steven M.Chief Brokerage Officer | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $334K 2,700 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 24 | Bement Kenneth BChief Accounting Officer | TRMBTRIMBLE INC. Tax withholding | F | $69K 1,167 sh | Sep 4, 2026 traded Sep 2, 2026 |
| 24 | Quirk Steven M.Chief Brokerage Officer | HOODRobinhood Markets, Inc. Open-market sale · 10b5-1 plan | SELL | $443K 3,599 sh | Sep 4, 2026 traded Sep 3, 2026 |
| 23 | Cunningham Bradley KramerChief Technology Officer | PAYSPaysign, Inc. Tax withholding | F | $95K 11.6K sh | Sep 4, 2026 traded Jun 30, 2026 |
| 23 | Tighe BrettChief Financial Officer | OKTAOkta, Inc. Open-market sale · 10b5-1 plan | SELL | $2.13M 13.1K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 23 | Tighe BrettChief Financial Officer | OKTAOkta, Inc. Open-market sale · 10b5-1 plan | SELL | $1.76M 10.8K sh | Sep 4, 2026 traded Sep 2, 2026 |